Market Challenges And Opportunities

Global Artificial Sperm Market: Drivers

The global artificial sperm market is expected to witness significant growth, as research institutes and academic research institutes are focusing on research and development for the treatment of infertility by artificial sperm to strengthen their position in the global artificial sperm market. For instance, in July 2020, University of California San Diego School of Medicine stated that they are developing a reliable method for production of human spermatogonial stem cell (SSC) in laboratory. The researchers of University of California San Diego are performing the research using sperm stem cell transplantation. The method involves biopsy of male human gonad to produce artificial spermatozoa and cultivation of spermatogonial stem cell with AKT pathway inhibitor.

Global Artificial Sperm Market - COVID-19 Impact Analysis

COVID-19 has affected several markets across the world. The COVID-19 pandemic has also affected the global artificial sperm market and various fertility centers are taking initiatives for the treatment of individuals having infertility conditions during this pandemic. For instance, in March 2020, Fertility Centers of New England, a medical group practice that specializes in reproductive endocrinology & infertility, stated that even during this COVID-19 pandemic, they would continue to treat individuals suffering from infertility conditions and will also follow all the guidelines prescribed by American Society of Reproductive Medicine such as use of personal protection equipment kit by healthcare professionals while treating patients, to check whether the patients are suffering from flu and cough before treatment to decrease the risk of spread of coronavirus disease.

Global Artificial Sperm Market: Restraints

Individuals suffering from infertility are treated with various procedures such as artificial insemination and in-vitro fertilizations. These procedures have drawbacks such as in-vitro fertilization is an expensive fertility treatment and thus, unaffordable for people in low and middle income countries. According to Planned Parenthood Federation of America, Inc, a nonprofit organization that provides reproductive health care in the U.S. and globally, stated that the treatment cost of in-vitro fertilization for an individual is around US$ 800 – US$ 1,000.